Literature DB >> 18623820

Salazopyrin in the Treatment of Rheumatoid Arthritis.

R J Sinclair1, J J Duthie.   

Abstract

Entities:  

Year:  1949        PMID: 18623820      PMCID: PMC1030728          DOI: 10.1136/ard.8.3.226

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  21 in total

Review 1.  Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

Authors:  T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.

Authors:  I H Nuver-Zwart; P L van Riel; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Salazopyrin in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; E P Butler; R A Crockson; A P Crockson; L Walsh
Journal:  Agents Actions       Date:  1978-06

4.  Sulphasalazine in rheumatoid arthritis: an old drug revived.

Authors:  V C Neumann; K A Grindulis
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

5.  History of the development of sulphasalazine in rheumatology.

Authors:  B McConkey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.

Authors:  T Pullar; H A Capell
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis.

Authors:  W C KUZELL; G M GARDNER
Journal:  Calif Med       Date:  1950-12

8.  Which component of sulphasalazine is active in rheumatoid arthritis?

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

9.  The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.

Authors:  A J Taggart; B J McDermott; S D Roberts
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

10.  Sulphasalazine and regression of rheumatoid nodules.

Authors:  H J Englert; G R Hughes; M J Walport
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.